IV Fluid Supply Updates

Progressnotes

MUSC's Medical Magazine | Fall 2017

Download This Issue (PDF)
Neoantigens could be cancer’s Achilles heel. This is a stylized image showing arrows (targeted therapies) penetrating a heel.

Fall 2017

MUSC Ranked State’s No. 1 Hospital Third Year in a Row 

MUSC Health Only Hospital in State to Achieve National Ranking by U.S. News & World Report

MUSC Health was named by U.S. News & World Report for the third year in a row as the No. 1 hospital in South Carolina, and one of the country’s top 50 hospitals in the treatment of ear, nose and throat disorders, gynecology, urology, and cancer. MUSC was also high-performing in gastroenterology & GI surgery, geriatrics, nephrology, neurology & neurosurgery, orthopedics, pulmonology, and rheumatology.

Patrick J. Cawley, M.D., MUSC Health CEO and MUSC Vice President of Health Affairs, said the ranking is a reflection of the team’s commitment to putting patients and families first, advancing innovation in the delivery of care and striving to make our communities healthier in ways that go beyond the hospital setting. “There are lots of ranking systems out there, but this particular designation means more than reputation,” Cawley said. “These rankings reflect strong patient outcomes, excellence in teaching the next generation of care providers, new innovations that improve health and strong health care leadership.”

Fall 2017 In Short

Dr. Besim Ogretmen

Bed to Bench Back to Bed

A synthetic peptide designed to treat HPV-negative cancer.

First of Its Kind

Novel inhibitor shown safe in first-in-kind phase 1 trial at Hollings Cancer Center.

Read More

Fall 2017 Features

Sylized Illustration of the CAR T Supercell

First Act

FDA approves the first-ever genetically modified adoptive cell transfer for pediatric acute lymphoblastic leukimia.
Image of man holding bow and arrow

Neoantigens

A multidisciplinary team of investigators is working at the interface of immunotherapy & genetics to expand treatment options for patients with lung cancer.
Dr. Jacqueline Kraveka and child assistant examine a doll.

Neuroblastoma Treatment

MUSC Children's Health is conducting pioneering clinical trials on upfront precision medicine therapy and relapse prevention for neuroblastoma.
Dr. Chadrick Denlinger in surgery

Same Gain Less Pain

Video-assisted thoracoscopic surgery achieves similar outcomes to thoracotomy in stage 1 non-small cell lung cancer with less pain and complications.
Dr. Philip Howe in laboratory

The RNA Family

A group of experts has formed at MUSC to study the roles of different RNAs in cancer.

Progressnotes CME Articles

Progressnotes is pleased to offer continuing education opportunities in an effort to meet the educational needs of our audience of health care professionals and to address the health care challenges of South Carolina, particularly its high burden of chronic illness. Each issue of Progressnotes, with the exception of the Year in Review, will offer one CME-eligible article. Read additional CME-eligible articles from past issues here.

This issue's CME article: A Question of Timing: Rethinking treatment sequencing in metastatic prostate cancer

New Chair of Pediatrics

MUSC Appoints New Chair of Pediatrics

Read More

New Chair of Pediatrics

MUSC Appoints New Chair of Pediatrics

Read More

New Physicians

New Physicians for Fall 2017

Read More